Interestingly, we sought to analyze the clinical significance of S100A7 and cPLA2 in relapse-free survival at 5 years in breast cancer patients treated with any chemotherapy using the ROC (receiver operating characteristics) plotter database. The gene discussed is S100A7; the disease is breast cancer.